|
1
|
Crew KD and Neugut AI: Epidemiology of
upper gastrointestinal malignancies. Semin Oncol. 31:450–464. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yu M, Zheng HC, Xia P, et al: Comparison
in pathological behaviours and prognosis of gastric cancers from
general hospitals between China and Japan. Indian J Med Res.
132:295–302. 2010.PubMed/NCBI
|
|
3
|
Heizmann CW, Fritz G and Schafer BW: S100
proteins: structure, functions and pathology. Front Biosci.
7:d1356–d1368. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tsai WC, Lin YC, Tsai ST, et al: Lack of
modulatory function of coding nucleotide polymorphism
S100A2_185G>A in oral squamous cell carcinoma. Oral Dis.
17:283–290. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sherbet GV and Lakshmi MS: S100A4 (MTS1)
calcium binding protein in cancer growth, invasion and metastasis.
Anticancer Res. 18:2415–2421. 1998.PubMed/NCBI
|
|
6
|
Kwak JM, Lee HJ, Kim SH, et al: Expression
of protein S100A4 is a predictor of recurrence in colorectal
cancer. World J Gastroenterol. 16:3897–3904. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Boye K and Maelandsmo GM: S100A4 and
metastasis: a small actor playing many roles. Am J Pathol.
176:528–535. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mishra SK, Siddique HR and Saleem M:
S100A4 calcium-binding protein is key player in tumor progression
and metastasis: preclinical and clinical evidence. Cancer
Metastasis Rev. 31:163–172. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zheng X, Yao Y, Xu Q, Tu K and Liu Q:
Evaluation of glioma-associated oncogene 1 expression and its
correlation with the expression of sonic hedgehog, E-cadherin and
S100a4 in human hepatocellular carcinoma. Mol Med Rep. 3:965–970.
2010.
|
|
10
|
Lo JF, Yu CC, Chiou SH, et al: The
epithelial-mesenchymal transition mediator S100A4 maintains
cancer-initiating cells in head and neck cancers. Cancer Res.
71:1912–1923. 2011. View Article : Google Scholar
|
|
11
|
Jenkinson SR, Barraclough R, West CR and
Rudland PS: S100A4 regulates cell motility and invasion in an in
vitro model for breast cancer metastasis. Br J Cancer. 90:253–262.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Takenaga K, Nakamura Y and Sakiyama S:
Expression of antisense RNA to S100A4 gene encoding an S100-related
calcium-binding protein suppresses metastatic potential of
high-metastatic Lewis lung carcinoma cells. Oncogene. 14:331–337.
1997. View Article : Google Scholar
|
|
13
|
Maelandsmo GM, Hovig E, Skrede M, et al:
Reversal of the in vivo metastatic phenotype of human tumor cells
by an anti-CAPL (mts1) ribozyme. Cancer Res. 56:5490–5498.
1996.PubMed/NCBI
|
|
14
|
Garrett SC, Varney KM, Weber DJ and
Bresnick AR: S100A4, a mediator of metastasis. J Biol Chem.
281:677–680. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Helfman DM, Kim EJ, Lukanidin E and
Grigorian M: The metastasis associated protein S100A4: role in
tumour progression and metastasis. Br J Cancer. 92:1955–1958. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Takenaga K, Nakamura Y, Sakiyama S,
Hasegawa Y, Sato K and Endo H: Binding of pEL98 protein, an
S100-related calcium-binding protein, to nonmuscle tropomyosin. J
Cell Biol. 124:757–768. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Watanabe Y, Usada N, Minami H, et al:
Calvasculin, as a factor affecting the microfilament assemblies in
rat fibroblasts transfected by src gene. FEBS Lett. 324:51–55.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kriajevska MV, Cardenas MN, Grigorian MS,
Ambartsumian NS, Georgiev GP and Lukanidin EM: Non-muscle myosin
heavy chain as a possible target for protein encoded by
metastasis-related mts-1 gene. J Biol Chem. 269:19679–19682.
1994.PubMed/NCBI
|
|
19
|
Saleem M, Kweon MH, Johnson JJ, et al:
S100A4 accelerates tumorigenesis and invasion of human prostate
cancer through the transcriptional regulation of matrix
metalloproteinase 9. Proc Natl Acad Sci USA. 103:14825–14830. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bjørnland K, Winberg JO, Odegaard OT, et
al: S100A4 involvement in metastasis: deregulation of matrix
metalloproteinases and tissue inhibitors of matrix
metalloproteinases in osteosarcoma cells transfected with an
anti-S100A4 ribozyme. Cancer Res. 59:4702–4708. 1999.PubMed/NCBI
|
|
21
|
Sobin LH and Wittekind CH: TNM
Classification of Malignant Tumors. 6th edition. John Wiley &
Sons; Hoboken, NJ: 2002
|
|
22
|
Zheng H, Takahashi H, Murai Y, et al:
Pathobiological characteristics of intestinal and diffuse-type
gastric carcinoma in Japan: an immunostaining study on the tissue
microarray. J Clin Pathol. 60:273–277. 2007. View Article : Google Scholar
|
|
23
|
Zheng HC, Li XH, Hara T, et al: Mixed-type
gastric carcinomas exhibit more aggressive features and indicate
the histogenesis of carcinomas. Virchows Arch. 452:525–534. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang YY, Ye ZY, Zhao ZS, Tao HQ and Chu
YQ: High-level expression of S100A4 correlates with lymph node
metastasis and poor prognosis in patients with gastric cancer. Ann
Surg Oncol. 17:89–97. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kim YJ, Kim MA, Im SA, et al:
Metastasis-associated protein S100A4 and p53 predict relapse in
curatively resected stage III and IV (M0) gastric cancer. Cancer
Invest. 26:152–158. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang H, Zhao K, Yu Q, Wang X, Song Y and
Li R: Evaluation of plasma and tissue S100A4 protein and mRNA
levels as potential markers of metastasis and prognosis in clear
cell renal cell carcinoma. J Int Med Res. 40:475–485. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang HY, Zheng XZ, Wang XH, Xuan XY, Wang
F and Li SS: S100A4 mediated cell invasion and metastasis of
esophageal squamous cell carcinoma via the regulation of MMP-2 and
E-cadherin activity. Mol Biol Rep. 39:199–208. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen D, Zheng XF, Yang ZY, et al: S100A4
silencing blocks invasive ability of esophageal squamous cell
carcinoma cells. World J Gastroenterol. 18:915–922. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kim JH, Kim CN, Kim SY, et al: Enhanced
S100A4 protein expression is clinicopathologically significant to
metastatic potential and p53 dysfunction in colorectal cancer.
Oncol Rep. 22:41–47. 2009.PubMed/NCBI
|
|
30
|
Ismail NI, Kaur G, Hashim H and Hassan MS:
S100A4 overexpression proves to be independent marker for breast
cancer progression. Cancer Cell Int. 8:122008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Matsumoto K, Irie A, Satoh T, et al:
Expression of S100A2 and S100A4 predicts for disease progression
and patient survival in bladder cancer. Urology. 70:602–607. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zheng HC, Xu XY, Yu M, Takahashi H, Masuda
S and Takano Y: The role of Reg IV gene and its encoding product in
gastric carcinogenesis. Hum Pathol. 41:59–69. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang YC: Geographic pathology of gastric
dysplasia in China. Semin Surg Oncol. 10:100–106. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Horiuchi A, Hayashi T, Kikuchi N, et al:
Hypoxia upregulates ovarian cancer invasiveness via the binding of
HIF-1α to a hypoxia-induced, methylation-free hypoxia response
element of S100A4 gene. Int J Cancer. 131:1755–1767.
2012.PubMed/NCBI
|
|
35
|
Liu J, Guo Y, Fu S, Yang M, Sun KL and Fu
WN: Hypo-methylation-induced expression of S100A4 increases the
invasiveness of laryngeal squamous cell carcinoma. Oncol Rep.
23:1101–1107. 2010.PubMed/NCBI
|
|
36
|
Feng LZ, Zheng XY, Zhou LX, et al:
Correlation between expression of S100A4 and VEGF-C, and lymph node
metastasis and prognosis in gastric carcinoma. J Int Med Res.
39:1333–1343. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kang YG, Jung CK, Lee A, Kang WK, Oh ST
and Kang CS: Prognostic significance of S100A4 mRNA and protein
expression in colorectal cancer. J Surg Oncol. 105:119–124. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Xie R, Loose DS, Shipley GL, Xie S,
Bassett RL Jr and Broaddus RR: Hypomethylation-induced expression
of S100A4 in endometrial carcinoma. Mod Pathol. 20:1045–1054. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang K, Zhang M, Zhao H, Yan B, Zhang D
and Liang J: S100A4 regulates motility and invasiveness of human
esophageal squamous cell carcinoma through modulating the AKT/Slug
signal pathway. Dis Esophagus. 25:731–739. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sack U, Walther W, Scudiero D, et al:
S100A4-induced cell motility and metastasis is restricted by the
Wnt/β-catenin pathway inhibitor calcimycin in colon cancer cells.
Mol Biol Cell. 22:3344–3354. 2011.PubMed/NCBI
|
|
41
|
Shen W, Chen D, Fu H, Liu S, Sun K and Sun
X: S100A4 protects gastric cancer cells from anoikis through
regulation of αv and α5 integrin. Cancer Sci. 102:1014–1018.
2011.PubMed/NCBI
|
|
42
|
Hua J, Chen D, Fu H, et al: Short hairpin
RNA-mediated inhibition of S100A4 promotes apoptosis and suppresses
proliferation of BGC823 gastric cancer cells in vitro and in vivo.
Cancer Lett. 292:41–47. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Xie R, Schlumbrecht MP, Shipley GL, Xie S,
Bassett RL Jr and Broaddus RR: S100A4 mediates endometrial cancer
invasion and is a target of TGF-beta1 signaling. Lab Invest.
89:937–947. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kho PS, Jankova L, Fung CL, et al:
Overexpression of protein S100A4 is independently associated with
overall survival in stage C colonic cancer but only in cytoplasm at
the advancing tumour front. Int J Colorectal Dis. 27:1409–1417.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ikenaga N, Ohuchida K, Mizumoto K, et al:
S100A4 mRNA is a diagnostic and prognostic marker in pancreatic
carcinoma. J Gastrointest Surg. 13:1852–1858. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Bandiera A, Melloni G, Freschi M, et al:
Prognostic factors and analysis of S100a4 protein in resected
pulmonary metastases from renal cell carcinoma. World J Surg.
33:1414–1420. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Tsuna M, Kageyama S, Fukuoka J, et al:
Significance of S100A4 as a prognostic marker of lung squamous cell
carcinoma. Anticancer Res. 29:2547–2554. 2009.PubMed/NCBI
|
